Showing results (111-120 of 133) with videos related to
Sort By:
Pageof 14
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 11, 2013
In vitro and in silico studies of MDM2/MDMX isoforms predict Nutlin-3A sensitivity in well/de-differentiated liposarcomasFabio Bozzi, Elena Conca, Erik Laurini, et al.Molecular Cancer Research : MCR|February 21, 2012
miRNA profiling in colorectal cancer highlights miR-1 involvement in MET-dependent proliferationJames F Reid, Viktorija Sokolova, Eugenio Zoni, et al.Tumori|August 19, 2004
45th annual meeting of the Italian Cancer Society. Bergamo, 9-12 November 2003Raffaella Giavazzi, Massimo Aglietta, Annalisa Astolfi, et al.Genes, Chromosomes & Cancer|November 3, 2011
Receptor tyrosine kinase pathway analysis sheds light on similarities between clear-cell sarcoma and metastatic melanomaTiziana Negri, Silvia Brich, Elena Conca, et al.Proceedings of the National Academy of Sciences of the United States of America|October 6, 2005
Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogeneMaria Grazia Borrello, Luisella Alberti, Andrew Fischer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2006
High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinomaLisa Licitra, Federica Perrone, Paolo Bossi, et al.Oncogene|June 15, 2004
BRAF alterations are associated with complex mutational profiles in malignant melanomaMaria Daniotti, Maria Oggionni, Tiziana Ranzani, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2006
Molecular and cytogenetic subgroups of oropharyngeal squamous cell carcinomaFederica Perrone, Simona Suardi, Elisa Pastore, et al.Cancer Research|October 19, 2006
RET is constitutively activated by novel tandem mutations that alter the active site resulting in multiple endocrine neoplasia type 2BAaron N Cranston, Cristiana Carniti, Kim Oakhill, et al.Journal of Experimental & Clinical Cancer Research : CR|January 25, 2017
MIF/CD74 axis is a target for novel therapies in colon carcinomatosisFabio Bozzi, Angela Mogavero, Luca Varinelli, et al.Pageof 14